Drug Use Evaluation of Direct Oral Anticoagulants (DOACs) in Patients With Advanced Cirrhosis

Objectives: Low molecular weight heparin and vitamin K antagonists are commonly used in cirrhotic patients requiring anticoagulation. However, their monitoring with anti-factor Xa and international normalized ratio (INR) may not be reliable in cirrhosis. Direct oral anticoagulants (DOACs) do not nee...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarboe, Lindsey, Dadlani, Apaar, Bandikatla, Sudeepthi, Wade, Regan, Barve, Ashutosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090206/
https://www.ncbi.nlm.nih.gov/pubmed/35547458
http://dx.doi.org/10.7759/cureus.24029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090206/
https://www.ncbi.nlm.nih.gov/pubmed/35547458
http://dx.doi.org/10.7759/cureus.24029

Ejemplares similares